What We're Developing

We're advancing treatments for a diverse range of indications.

How The Science Works

We're developing a treatment that modulates the immune system and brings it back into balance. Emergo's approach accomplishes this without causing immunosuppression.

Learn More →

The Team Behind It

Experts in research, clinical development, manufacturing, and regulatory affairs advancing groundbreaking therapies for unmet needs.

Meet The Team →

Welcome to Emergo

We're committed to creating groundbreaking medications that restore equilibrium to your immune system.

Emergo Therapeutics was founded in 2016 to develop a treatment for hypercytokinemia, or cytokine storm. There are a number of conditions where overactive mast cells and other components of the immune system cause a range of conditions. Despite strong evidence that reducing the activity of mast cells was effective, few effective treatments were available. Our work focuses on curtailing the release of inflammation-inducting cytokines from these cells, with the goal of revolutionizing treatment approaches and improving patient outcomes.